Microsoft Dynamics 365 For Biotech & Pharma
Adopt a unified operational solution for scientific innovation and commercial execution
Operational Control For Science-led Growth
Biotech and pharmaceutical organisations operate at the intersection of scientific innovation, regulatory control, and commercial pressure. Organisations must maintain tight governance over cost, partners, and data, while enabling research teams to move quickly through discovery, trials, and scale-up.
From early-stage R&D through to clinical trials and commercial launch, success depends on operational control without compromising scientific momentum or regulatory discipline.
Microsoft Dynamics enables leadership teams to manage finance, projects, suppliers, and stakeholder relationships in one controlled environment, supporting both regulatory expectations and commercial readiness.
Dynamics 365 For Biotech & Pharma
Challenges In Biotech & Pharma
Biotech and pharma organisations face structural pressures that generic business systems struggle to support:
- GxP-aligned financial and operational controls across MHRA, EMA, and FDA environments
• Long development timelines with high burn rates and uncertain revenue profiles
• Fragmented data between R&D, finance, CROs, CDMOs, and clinical operations
• Limited visibility over true programme cost, funding utilisation, and supplier exposure
• Increasing scrutiny from investors and partners on governance, auditability, and capital efficiency
• The operational shift from research-led activity to regulated commercial operations
Without a single operational backbone, leadership teams lack real-time oversight of trial costs, supplier commitments, and financial runway. Manual reporting and disconnected systems increase regulatory risk and slow decision-making at critical growth stages.
How Microsoft Dynamics 365 Supports Biotech And Pharma Operations
Dynamics 365 enables biotech and pharma organisations to apply enterprise-grade rigour while retaining start-up agility. By unifying finance, project governance, supplier management, and CRM in one cloud platform, organisations gain a single source of truth across R&D programmes, clinical milestones, manufacturing partners, and investor reporting.
Core Microsoft Dynamics 365 workloads used in biotech and pharma include:
Finance & Operations Control
Provides structured financial management, project accounting, and cost tracking across research programmes and clinical trials. Finance teams gain accurate burn-rate visibility, milestone costing, and grant allocation control.
Project & Programme Governance
Dynamics 365 Project Operations supports structured management of R&D programmes, clinical phases, and partner-led workstreams. Enable visibility across timelines, budgets, and deliverables, improving confidence in trial execution and resource planning.
Supplier & Partner Management
Dynamics 365's CRM capabilities centralises supplier records, contract tracking, and analysis ro improve control over outsourced research, manufacturing, and trial services. Performance tracking reduces dependency risk and strengthens commercial leverage.
Compliance-Ready Reporting & Audit Trails
Role-based access, controlled workflows, and automated financial reporting support audit readiness and regulatory scrutiny. This simplifies preparation for investor due diligence, partner audits, and regulatory submissions.
Commercial & Stakeholder Relationship Management
Dynamics 365 Sales supports NHS engagement, distributor relationships, partner management, and post-market operations as organisations move towards commercialisation. It also strengthens investor communications and collaboration with research partners.
Forecasting & Scenario Planning
Integrated forecasting models different trial outcomes, funding scenarios, and commercial timelines. Leadership teams can test assumptions and plan capital deployment with greater confidence.
Cyber Security & Data Protection
Built on Microsoft’s cloud platform, Dynamics 365 benefits from enterprise-grade security, identity management, and audit logging, improving protection of intellectual property and sensitive research data.
What’s The Value Of Dynamics 365
Microsoft Dynamics 365 provides a regulated operational foundation for biotech and pharma organisations moving from discovery to commercial scale. It can unify finance, projects, suppliers, and CRM into a single, controlled platform that supports:
- Stronger cost governance across R&D and clinical activity
- Clear visibility over funding, grants, and investor commitments
- Reduced regulatory and audit risk
- Scalable operations as organisations approach market readiness
The result is faster decision-making, improved capital efficiency, and an operational platform that grows with the organisation.
Return On Investment
Biotech and pharma organisations adopting Dynamics 365 achieve measurable ROI through tighter control of R&D spend, reduced reporting overhead, and improved visibility across supplier commitments and funding sources.
Automation of compliance-ready reporting reduces audit and regulatory preparation effort, while integrated forecasting improves capital efficiency and extends financial runway without increasing headcount.
With Dynamics 365, operational discipline becomes a competitive advantage rather than an administrative burden.
Case Study: Finance Transformation For Medical Equipment Company
Explore how Microsoft Dynamics 365 helped overcome accounting limitations within its operations:
More
Dynamics 365 for Biotech & Pharma
Why Work With Akita
Akita works with regulated and data-sensitive organisations that require strong financial control, structured operations, and scalable platforms.
For biotech and pharma organisations, this means systems designed around:
- Accurate R&D and programme cost tracking
- Controlled financial and supplier processes
- Visibility across CROs, CDMOs, and funding partners
- Secure handling of sensitive operational and commercial data
- Platforms that scale from discovery through to commercialisation
Akita aligns Dynamics 365 to the realities of biotech operations, not generic ERP models. The focus is on high adoption, low operational risk, and systems that support growth rather than restrict research teams.
Dynamics 365 for Biotech & Pharma
Next Steps To Adoption
If you are managing growth, preparing for clinical scale-up, or transitioning towards commercial operations, Dynamics 365 provides the operational backbone to support that journey.
Akita helps biotech and pharma organisations assess their current operational maturity, define the right Dynamics 365 architecture, and implement systems that meet both commercial and regulatory needs.
To explore whether Dynamics 365 is right for your organisation, arrange a discovery session to align capabilities with your funding model, regulatory environment, and growth plans:
Let’s Talk Transformation
Create a scalable foundation for biotech growth with Dynamics 365 and Akita. Reach out today:
Contact Us
